Latvian Early Atherosclerosis Registry

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

April 1, 2019

Primary Completion Date

December 31, 2030

Study Completion Date

December 31, 2030

Conditions
Coronary Artery DiseaseAtherosclerosis, Coronary
Interventions
DIAGNOSTIC_TEST

Near infrared spectroscopy

Near infrared spectroscopy (NIRS) is an intravascular imaging technique. Patients after coronary angiography with or without angioplasty will undergo NIRS if deemed suitable by the interventionalist. NIRS has a high sensitivity and specificity for lipid core plaque detection.

GENETIC

Genetic testing for LDLR, APOB, PCSK9 and LDLRAP1 mutations and niR-126, -145 and -155 expression.

Patients without explicit atherosclerosis risk factors and known genetic disorders will undergo genetic testing for LDLR, APOB, PCSK9 and LDLRAP1 genes in order to evaluate the presence of gene variations as a cause for early atherosclerosis. MiRNA-126, -145 and -155 expression in patients serum samples will be evaluated and correlated with plaque lipid core in near infrared spectroscopy (NIRS) imaging.

Trial Locations (1)

Unknown

RECRUITING

Pauls Stradins Clinical University hospital, Riga

All Listed Sponsors
lead

Pauls Stradins Clinical University Hospital

OTHER